Limited replication of human cytomegalovirus in a trophoblast cell line. (2021)

First Author: Hyde K
Attributed to:  Utilising proteomics to develop anti-HCMV immunotherapy funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1099/jgv.0.001683

PubMed Identifier: 34816792

Publication URI: http://europepmc.org/abstract/MED/34816792

Type: Journal Article/Review

Volume: 102

Parent Publication: The Journal of general virology

Issue: 11

ISSN: 0022-1317